AMEDISYS INC - Common Stock, par value $0.001 per share (AMED)

Historical Holders from Q1 2014 to Q3 2025

Symbol: AMED
Type / Class: Equity / Common Stock, par value $0.001 per share
Shares outstanding: 33M
All holders as of 30 Sep 2025: Q3 2025
Total 13F shares, excl. options: 542
Holdings value: $61.6K
% of all portfolios: 0%
Grand Portfolio weight change: -0.005%
Number of holders: 4
Number of buys: 2
Number of sells: -312
Average Value change %: -0.01%
Average buys %: +0%
Average sells %: -0.01%

Reported Shares, Excluding Options vs Price

Reported Value, Excluding Options

Total Investors

Significant Owners of AMEDISYS INC - Common Stock, par value $0.001 per share (AMED)

Filer	Ownership	Change %	Holdings Value	Net Change	Nb Shares	Change %	Reporting Name	Report Period
GOLDMAN SACHS GROUP INC	0%	-108%	$19.2K	-$179M	190	-100%	THE GOLDMAN SACHS GROUP, INC.	30 Sep 2025

Institutional Holders of AMEDISYS INC - Common Stock, par value $0.001 per share (AMED)

Period	Reported Shares, Excl. Options	Value, Excl. Options	Change	Puts Notional Value	Calls Notional Value	Price	Investors
2025 Q3	542	$61.6K	-$3.24B	0	0	$99.80	4
2025 Q2	33M	$3.25B	+$158M	242M	7.71M	$98.39	318
2025 Q1	31.7M	$2.94B	-$44.2M	148M	6.69M	$92.63	302
2024 Q4	32.1M	$2.91B	+$45.5M	285M	71.1M	$90.79	289
2024 Q3	31.1M	$3B	+$6M	95.8M	12.7M	$96.51	282
2024 Q2	31.1M	$2.85B	+$79.3M	90.4M	14M	$91.80	287
2024 Q1	30.6M	$2.82B	-$78.6M	81.2M	12.5M	$92.16	280
2023 Q4	31.5M	$2.99B	+$158M	86.3M	17.2M	$95.06	285
2023 Q3	29.9M	$2.79B	-$4.37M	57.5M	5.31M	$93.40	284
2023 Q2	30M	$2.74B	-$71.3M	23.2M	7.33M	$91.44	297
2023 Q1	31.3M	$2.3B	+$6.76M	1.62M	5.49M	$73.55	276
2022 Q4	31.1M	$2.6B	-$51.5M	4.59M	3.02M	$83.54	271
2022 Q3	31.5M	$3.05B	+$112M	4.55M	10.8M	$96.79	268
2022 Q2	29.3M	$3.08B	-$83.6M	16.7M	11.3M	$105.12	271
2022 Q1	30.2M	$5.2B	+$176M	48.5M	54.9M	$172.29	317
2021 Q4	29.3M	$4.73B	+$74.3M	27M	31.4M	$161.88	314
2021 Q3	28.3M	$4.22B	-$208M	49M	34.8M	$149.10	340
2021 Q2	28.9M	$7.08B	+$78.6M	44.1M	20.3M	$244.93	362
2021 Q1	28.5M	$7.55B	-$67.8M	39.6M	30.8M	$264.79	382
2020 Q4	29.1M	$8.54B	+$83.4M	54.4M	53.5M	$293.33	392
2020 Q3	28.9M	$6.83B	-$191M	43.4M	36M	$236.43	384
2020 Q2	29.7M	$5.9B	+$147M	30.8M	34.3M	$198.54	343
2020 Q1	29M	$5.32B	+$4.55M	45.6M	30.9M	$183.54	323
2019 Q4	29M	$4.84B	-$101M	42.4M	21.9M	$166.92	319
2019 Q3	29.8M	$3.9B	+$122M	38.2M	12.3M	$131.01	278
2019 Q2	29M	$3.52B	+$145M	25.2M	11.3M	$121.41	282
2019 Q1	28.2M	$3.48B	-$141M	22.2M	9.23M	$123.26	312
2018 Q4	29.4M	$3.44B	-$109M	12.9M	14M	$117.11	295
2018 Q3	30.2M	$3.77B	-$16.3M	16.7M	10.6M	$124.96	264
2018 Q2	30.5M	$2.6B	-$172M	6.84M	11.5M	$85.46	212
2018 Q1	32.7M	$1.97B	+$27.4M	4.5M	3.36M	$60.34	192
2017 Q4	33.1M	$1.74B	+$26.7M	1.83M	2.52M	$52.71	186
2017 Q3	32.5M	$1.82B	-$52.8M	2.68M	8.61M	$55.96	161
2017 Q2	33M	$2.08B	-$3.91M	18.2M	2.55M	$62.81	167
2017 Q1	33.2M	$1.7B	+$309M	3.15M	3.56M	$51.09	152
2016 Q4	32.5M	$1.39B	+$33.4M	827K	2.36M	$42.63	157
2016 Q3	31.7M	$1.5B	+$69.1M	1.33M	2.55M	$47.44	152
2016 Q2	31M	$1.56B	+$23.3M	1.78M	1.66M	$50.48	165
2016 Q1	30.5M	$1.47B	+$25.2M	4.38M	1.92M	$48.34	166
2015 Q4	30.2M	$1.19B	-$2.78M	807K	5.84M	$39.32	164
2015 Q3	30.3M	$1.15B	+$32.9M	1.26M	6.48M	$37.97	170
2015 Q2	29.4M	$1.17B	+$44.7M	10.9M	12.7M	$39.73	141
2015 Q1	28.3M	$759M	-$11.4M	1.27M	4.14M	$26.78	129
2014 Q4	28.7M	$843M	-$23.2M	2.49M	5.27M	$29.35	136
2014 Q3	30M	$606M	-$7.59M	975K	3.37M	$20.17	123
2014 Q2	30.6M	$512M	+$6.07M	1.31M	4.54M	$16.74	121
2014 Q1	30.3M	$451M	+$10.9M	3.01M	1.41M	$14.89	118